704 related articles for article (PubMed ID: 22680408)
1. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.
Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL
Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis.
Tortelli R; Copetti M; Ruggieri M; Cortese R; Capozzo R; Leo A; D'Errico E; Mastrapasqua M; Zoccolella S; Pellegrini F; Simone IL; Logroscino G
Eur J Neurol; 2015 Jan; 22(1):215-8. PubMed ID: 24750431
[TBL] [Abstract][Full Text] [Related]
3. Significance of CSF NfL and tau in ALS.
Schreiber S; Spotorno N; Schreiber F; Acosta-Cabronero J; Kaufmann J; Machts J; Debska-Vielhaber G; Garz C; Bittner D; Hensiek N; Dengler R; Petri S; Nestor PJ; Vielhaber S
J Neurol; 2018 Nov; 265(11):2633-2645. PubMed ID: 30187162
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis.
Scarafino A; D'Errico E; Introna A; Fraddosio A; Distaso E; Tempesta I; Morea A; Mastronardi A; Leante R; Ruggieri M; Mastrapasqua M; Simone IL
J Neurol; 2018 Oct; 265(10):2353-2362. PubMed ID: 30116940
[TBL] [Abstract][Full Text] [Related]
5. Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease.
Poesen K; De Schaepdryver M; Stubendorff B; Gille B; Muckova P; Wendler S; Prell T; Ringer TM; Rhode H; Stevens O; Claeys KG; Couwelier G; D'Hondt A; Lamaire N; Tilkin P; Van Reijen D; Gourmaud S; Fedtke N; Heiling B; Rumpel M; Rödiger A; Gunkel A; Witte OW; Paquet C; Vandenberghe R; Grosskreutz J; Van Damme P
Neurology; 2017 Jun; 88(24):2302-2309. PubMed ID: 28500227
[TBL] [Abstract][Full Text] [Related]
6. Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis.
Chen X; Chen Y; Wei Q; Ou R; Cao B; Zhao B; Shang HF
BMC Neurol; 2016 Sep; 16():173. PubMed ID: 27634542
[TBL] [Abstract][Full Text] [Related]
7. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study.
Gagliardi D; Faravelli I; Meneri M; Saccomanno D; Govoni A; Magri F; Ricci G; Siciliano G; Pietro Comi G; Corti S
J Cell Mol Med; 2021 Apr; 25(8):3765-3771. PubMed ID: 33609080
[TBL] [Abstract][Full Text] [Related]
9. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.
Lu CH; Macdonald-Wallis C; Gray E; Pearce N; Petzold A; Norgren N; Giovannoni G; Fratta P; Sidle K; Fish M; Orrell R; Howard R; Talbot K; Greensmith L; Kuhle J; Turner MR; Malaspina A
Neurology; 2015 Jun; 84(22):2247-57. PubMed ID: 25934855
[TBL] [Abstract][Full Text] [Related]
10. Neurofilaments in Sporadic and Familial Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
Shahim P; Norato G; Sinaii N; Zetterberg H; Blennow K; Chan L; Grunseich C
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674431
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.
Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P;
J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis.
Fialová L; Svarcová J; Bartos A; Ridzon P; Malbohan I; Keller O; Rusina R
Eur J Neurol; 2010 Apr; 17(4):562-6. PubMed ID: 19968709
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of CSF neurofilament light and heavy chain protein in MS.
Kuhle J; Plattner K; Bestwick JP; Lindberg RL; Ramagopalan SV; Norgren N; Nissim A; Malaspina A; Leppert D; Giovannoni G; Kappos L
Mult Scler; 2013 Oct; 19(12):1597-603. PubMed ID: 23529999
[TBL] [Abstract][Full Text] [Related]
14. CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum.
Illán-Gala I; Alcolea D; Montal V; Dols-Icardo O; Muñoz L; de Luna N; Turón-Sans J; Cortés-Vicente E; Sánchez-Saudinós MB; Subirana A; Sala I; Blesa R; Clarimón J; Fortea J; Rojas-García R; Lleó A
Neurology; 2018 Oct; 91(17):e1619-e1628. PubMed ID: 30291183
[TBL] [Abstract][Full Text] [Related]
15. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.
Rossi D; Volanti P; Brambilla L; Colletti T; Spataro R; La Bella V
J Neurol; 2018 Mar; 265(3):510-521. PubMed ID: 29322259
[TBL] [Abstract][Full Text] [Related]
16. Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Shi J; Qin X; Chang X; Wang H; Guo J; Zhang W
J Cell Mol Med; 2022 Jan; 26(2):583-587. PubMed ID: 34866307
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.
Gaiani A; Martinelli I; Bello L; Querin G; Puthenparampil M; Ruggero S; Toffanin E; Cagnin A; Briani C; Pegoraro E; Sorarù G
JAMA Neurol; 2017 May; 74(5):525-532. PubMed ID: 28264096
[TBL] [Abstract][Full Text] [Related]
18. Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS.
Halbgebauer S; Steinacker P; Verde F; Weishaupt J; Oeckl P; von Arnim C; Dorst J; Feneberg E; Mayer B; Rosenbohm A; Silani V; Ludolph AC; Otto M
J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):68-74. PubMed ID: 34417339
[TBL] [Abstract][Full Text] [Related]
19. Comparison of neurofilament light and heavy chain in spinal muscular atrophy and amyotrophic lateral sclerosis: A pilot study.
Li JY; Dai Y; Sun XH; Ren HT; Shen DC; Yang XZ; Liu MS; Cui LY
Brain Behav; 2023 May; 13(5):e2997. PubMed ID: 37070132
[TBL] [Abstract][Full Text] [Related]
20. Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS.
Kasai T; Kojima Y; Ohmichi T; Tatebe H; Tsuji Y; Noto YI; Kitani-Morii F; Shinomoto M; Allsop D; Mizuno T; Tokuda T
Ann Clin Transl Neurol; 2019 Dec; 6(12):2489-2502. PubMed ID: 31742901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]